Colorectal Cancer Market 2019-2027: COVID-19 Analysis, Drivers, Restraints, Opportunities & Threats | Epigenomics AG, Novigenix SA, Abbott, Amgen Inc., Natera

According to The Insight Partners market research titled 'Colorectal Cancer to 2027 – Global Analysis and Forecasts by Modality, and End User'. The global Colorectal Cancer market is anticipated to reach US$ 22,953.8 Mn in 2027 from US$ 16,339.9 Mn in 2018. The market is anticipated to grow with a CAGR of 4.0% from 2019-2027. The report provides the trends prevailing in the global colorectal cancer market and the factors driving the market along with those that act as hindrances.

The leading companies operating in the colorectal cancer market include Epigenomics AG, Novigenix SA, Clinical Genomics Technologies Pty Ltd., EDP Biotech Corporation, Volitionrx Limited, Abbott Laboratories, Amgen Inc., F. Hoffmann-La Roche AG, Bruker Corporation, Quest Diagnostics Incorporated, Natera, Inc., and Guardant Health, Inc among others.

Download PDF Sample of Colorectal Cancer Market with Insights @ https://www.theinsightpartners.com/sample/TIPRE00006881/?utm_source=OpenPR&utm_medium=10291

The market for colorectal cancer is expected to grow, owing to factors such as increasing prevalence of colorectal cancer, new product launches and benefits offered by generic drugs. Moreover, growing pharmaceutical industry in emerging economies is likely to have a positive impact on the growth of the market in the coming years.

The global colorectal cancer market, based on the modality, is segmented into diagnosis type, therapy type, and imaging type. In 2018, the diagnosis type segment held the largest market share of the colorectal cancer market. This segment is also projected to dominate the market in 2027 as it emphasizes the need for early recognition of neoplasms, or in the asymptomatic or pre-cancerous stage.

Modality-Based Insights

In terms of modality, the Colorectal Cancer in healthcare market is segmented into diagnosis type, therapy type, imaging type. The diagnosis type segment held a largest share of the market in 2018. Moreover, this segment is anticipated to register the highest CAGR in the market during the forecast period.

End User-Based Insights

In terms of end user, the Colorectal Cancer in healthcare market is segmented into hospitals, diagnostic research laboratories. In 2018, the hospitals segment held the largest share of the market, by end user as hospitals are primary healthcare centers for the people.

Strategic Insights

The Colorectal Cancer in healthcare market players are adopting the product launch and expansion strategies to cater to changing customer demands worldwide, which also allows them to maintain their brand name globally.

Market Segmentation:

Colorectal Cancer in Healthcare Market – by Modality

Software Solution
Hardware
Services

Colorectal Cancer in Healthcare Market – by End User

Hospitals & Healthcare Providers
Patients
Pharma & Biotech Companies
Healthcare Payers
Others

Interested In Purchasing This Report? Click Here @ https://www.theinsightpartners.com/buy/TIPRE00006881/?utm_source=OpenPR&utm_medium=10291

Contact Us

Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Semiconductors, Healthcare, Manufacturing, Automotive and Defense.

This release was published on openPR.